---
title: "iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement | ISPC Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285787160.md"
description: "iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement | ISPC Stock News"
datetime: "2026-05-08T17:05:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285787160.md)
  - [en](https://longbridge.com/en/news/285787160.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285787160.md)
---

# iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement | ISPC Stock News

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement | ISPC Stock News

### Related Stocks

- [ISPC.US](https://longbridge.com/en/quote/ISPC.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership](https://longbridge.com/en/news/286787574.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)